FDA Clearance Tracker · K223085
Miris Human Milk Analyzer (HMA)
Last checked: Nov 19, 2026Latest source record: Sep 29, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 29, 2023
Substantially Equivalent
Time to decision
364 days
Received Sep 30, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K223085
- Device name
- Miris Human Milk Analyzer (HMA)
- Applicant
- Miris AB
- Applicant location
- Uppsala, SE
- Received
- Sep 30, 2022
- Decided
- Sep 29, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Breast Milk Macronutrients Test System (QEI)
- Device class
- Class II
- Regulation
- 21 CFR 862.1493
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QEI. The earliest in FDA's data is DEN180007, decided Dec 21, 2018.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K223085
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Miris AB
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Miris Human Milk AnalyzerNew device typeDe Novo
DEN180007 · Decided Dec 21, 2018 · 312 days after receipt
Device type: Breast Milk Macronutrients Test System (QEI) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.